THE SINGLE BEST STRATEGY TO USE FOR IMDK

The decrease in paclitaxel CL observed while in the existence of zosuquidar led to a increase in time the plasma paclitaxel concentration remains previously mentioned 0.1 mol L−1, which is thought being a marker of both toxicity (neutropenia) and efficacy [1]. Although the influence of zosuquidar on the toxicity of the clinically utilized dose of